Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment...

Area of Science:

• Cardiology
• Public Health
• Addiction Medicine

Background:

• Smoking is a major risk factor for myocardial infarction (MI).
• Effective smoking cessation interventions are crucial for post-MI patient recovery and secondary prevention.
• Optimizing the implementation of evidence-based cessation methods in clinical practice is essential.

Purpose of the Study:

• To compare the effectiveness of smoking cessation at 2-months post-MI before and after implementing optimized evidence-based cessation routines.
• To assess adherence to the implemented routines.
• To evaluate the prognostic value of specific cessation interventions on smoking cessation.

Main Methods:

• A comparative study was conducted across six Swedish hospitals.
• Logistic regression was used to compare smoking cessation rates at 2-months pre- and post-implementation.
• Data collected included patient counseling during admission, medication prescription (nicotine replacement therapy, varenicline), and post-discharge telephone contact.

Main Results:

• Smoking cessation rates at 2-months increased from 54% to 65% after routine implementation (OR 1.60).
• Patients receiving counseling during admission showed higher cessation rates (74%).
• Post-discharge telephone contact (adjusted OR 2.74) and varenicline prescription (adjusted OR 0.39) were significant predictors of cessation.

Conclusions:

• Optimized, evidence-based smoking cessation methods can be effectively integrated into routine clinical practice for post-MI patients.
• Implementation of these routines led to improved smoking cessation rates.
• Targeted interventions like post-discharge contact and specific medications enhance cessation success.